Transaction overview
On January 8, 2025, Currier Plastics completed the acquisition of MOS Plastics to expand its services and deepen its capabilities in the life sciences sector while establishing a significant presence on the West Coast. Terms of the transaction were not disclosed publicly. MOS is headquartered in San Jose, California, and provides custom-molded precision components, tooling, and sub-assemblies primarily for pharmaceutical, medical technology, and diagnostic customers. The acquisition follows Currier Plastics' earlier purchase of Springboard Manufacturing based in Rancho Cordova, also in California.
Deal structure and financing
Details regarding the equity split, debt financing, leverage metrics, lock-up terms, and seller retained stakes remain undisclosed. Debt financing was provided by Fidelity. MBS Advisors acted as financial advisor to MOS Plastics during the transaction process. The deal’s close on January 8th suggests a rapid timeline given its announcement date of the same day.
Strategic context
Currier Plastics sought to expand its service offerings and life sciences capabilities while building a presence in California, an important market for medical manufacturing due to its concentration of biotechnology firms and research institutions. The acquisition of MOS Plastics enables Currier to tap into these local resources and customer bases more effectively. Additionally, MOS’s extensive expertise in producing components for pharmaceuticals and medical devices aligns with Currier's existing business model focused on serving life sciences customers.
MOS Plastics' owner HC Private Investments sold the company to focus its portfolio on other opportunities. The rationale behind this move includes a strategic realignment of resources towards sectors better aligned with current market dynamics or internal investment criteria. With the sale, MOS can also benefit from Currier’s larger scale and operational expertise, facilitating future growth.
Regulatory path
No information is available regarding regulatory reviews, filings, or required remedies for this acquisition. Given that both companies are based in California, it is likely that local antitrust authorities were involved in reviewing the transaction, particularly if the combined entity attains a significant market share within specific product segments. Potential jurisdictions may include the Federal Trade Commission (FTC) and the Antitrust Division of the Department of Justice (DOJ), although this remains speculative without concrete regulatory filings or statements.